Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis

Haibo Liu; Shicheng Luo; Xiaofeng Sha; Zhiping Chen; Dongdong Yang

doi:10.2478/acph-2023-0033

Abstract

Cancer-associated fibroblasts (CAFs) play critical roles in the tumor microenvironment and exert tumor-promoting or tumor-retarding effects on cancer development. Astragaloside IV has been suggested to rescue the pathological impact of CAFs in gastric cancer. This study aimed to investigate the potential mechanism of astragaloside IV in the regulation of CAF pathological functions in gastric cancer development. Homeobox A6 (HOXA6), and Zinc Finger and BTB Domain Containing 12 (ZBTB12) are highly expressed in gastric CAFs compared with normal fibroblasts (NFs) based on the GSE62740 dataset. We found that astragaloside IV-stimulated CAFs suppressed cell growth, migration, and invasiveness of gastric cancer cells. HOXA6 and ZBTB12 were downregulated after astragaloside IV treatment in CAFs. Further analysis revealed that HOXA6 or ZBTB12 knockdown in CAFs also exerted inhibitory effects on the malignant phenotypes of gastric cells. Additionally, HOXA6 or ZBTB12 overexpression in CAFs enhanced gastric cancer cell malignancy, which was reversed after astragaloside IV treatment. Moreover, based on the hTFtarget database, ZBTB12 is a target gene that may be transcriptionally regulated by HOXA6. The binding between HOXA6 and ZBTB12 promoter in 293T cells and CAFs was further confirmed. HOXA6 silencing also induced the downregulation of ZBTB12 mRNA and protein in CAFs. Astragaloside IV was demonstrated to regulate the expression of ZBTB12 by mediating the transcriptional activity of HOXA6. Our findings shed light on the therapeutic value of astragaloside IV for gastric cancer.

References

H. Sung, J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal and F. Bray, Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries, CA Cancer J. Clin. 71(3) (2021) 209–249; https://doi.org/10.3322/caac.21660
Search in Google Scholar Back to article
Y. Zeng and R. U. Jin, Molecular pathogenesis, targeted therapies, and future perspectives for gastric cancer, Semin. Cancer Biol. 86(3) (2022) 566–582; https://doi.org/10.1016/j.semcancer.2021.12.004
Search in Google Scholar Back to article
E. C. Smyth, M. Nilsson, H. I. Grabsch, N. C. van Grieken and F. Lordick, Gastric cancer, Lancet 396 (2020) 635–648; https://doi.org/10.1016/s0140-6736(20)31288-5
Search in Google Scholar Back to article
S. S. Joshi and B. D. Badgwell, Current treatment and recent progress in gastric cancer, CA Cancer J. Clin. 71(3) (2021) 264–279; https://doi.org/10.3322/caac.21657
Search in Google Scholar Back to article
Y. Xiao and D. Yu, Tumor microenvironment as a therapeutic target in cancer, Pharmacol. Ther. 221 (2021) Article ID 107753 (30 pages); https://doi.org/10.1016/j.pharmthera.2020.107753
Search in Google Scholar Back to article
T. A. Karakasheva, E. W. Lin, Q. Tang, E. Qiao, T. J. Waldron, M. Soni, A. J. Klein-Szanto, V. Sahu, D. Basu, S. Ohashi, K. Baba, Z. T. Giaccone, S. R. Walker, D. A. Frank, E. P. Wileyto, Q. Long, M. C. Dunagin, A. Raj, J. A. Diehl, K. K. Wong, A. J. Bass and A. K. Rustgi, IL-6 mediates cross-talk between tumor cells and activated fibroblasts in the tumor microenvironment, Cancer Res. 78(17) (2018) 4957–4970; https://doi.org/10.1158/0008-5472.can-17-2268
Search in Google Scholar Back to article
H. Sun, X. Wang, X. Wang, M. Xu and W. Sheng, The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer, Cell Death Dis. 13 (2022) Article ID 874 (9 pages); https://doi.org/10.1038/s41419-022-05320-8
Search in Google Scholar Back to article
H. Zhang, T. Deng, R. Liu, T. Ning, H. Yang, D. Liu, Q. Zhang, D. Lin, S. Ge, M. Bai, X. Wang, L. Zhang, H. Li, Y. Yang, Z. Ji, H. Wang, G. Ying and Y. Ba, CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer, Mol. Cancer 19 (2020) Article ID 43 (17 pages); https://doi.org/10.1186/s12943-020-01168-8
Search in Google Scholar Back to article
X. Liu, L. Yao, J. Qu, L. Liu, N. Lu, J. Wang and J. Zhang, Cancer-associated fibroblast infiltration in gastric cancer: the discrepancy in subtypes pathways and immunosuppression, J. Transl. Med. 19 (2021) Article ID 325 (16 pages); https://doi.org/10.1186/s12967-021-03012-z
Search in Google Scholar Back to article
G. Itoh, K. Takagane, Y. Fukushi, S. Kuriyama, M. Umakoshi, A. Goto, K. Yanagihara, M. Yashiro and M. Tanaka, Cancer-associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T-cell suppression, Mol. Oncol. 16(1) (2022) 166–187; https://doi.org/10.1002/1878-0261.13077
Search in Google Scholar Back to article
Y. Yan, L. F. Wang and R. F. Wang, Role of cancer-associated fibroblasts in invasion and metastasis of gastric cancer, World J. Gastroenterol. 21(33) (2015) 9717–9726; https://doi.org/10.3748/wjg.v21.i33.9717
Search in Google Scholar Back to article
J. Zheng, M. Wu, H. Wang, S. Li, X. Wang, Y. Li, D. Wang and S. Li, Network pharmacology to unveil the biological basis of health-strengthening herbal medicine in cancer treatment, Cancers (Basel) 10(46) (2018) Article ID 461 (23 pages); https://doi.org/10.3390/cancers10110461
Search in Google Scholar Back to article
J. Liu, S. Wang, Y. Zhang, H. T. Fan and H. S. Lin, Traditional Chinese medicine and cancer: History, present situation, and development, Thorac. Cancer 6(5) (2015) 561–569; https://doi.org/10.1111/1759-7714.12270
Search in Google Scholar Back to article
J. Zhang, J. Gao, J. Cui, Y. Wang, Y. Jin, D. Zhang, D. Lin and J. Lin, Tumor-associated macrophages in tumor progression and the role of traditional Chinese medicine in regulating TAMs to enhance antitumor effects, Front. Immunol. 13 (2022) Article ID 1026898 (10 pages); https://doi.org/10.3389/fimmu.2022.1026898
Search in Google Scholar Back to article
Y. Luo, S. Yin, J. Lu, S. Zhou, Y. Shao, X. Bao, T. Wang, Y. Qiu and H. Yu, Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment, Cancer Cell Int. 21 (2021) Article ID 386 (20 pages); https://doi.org/10.1186/s12935-021-02085-6
Search in Google Scholar Back to article
Y. Zhang, Y. Lou, J. Wang, C. Yu and W. Shen, Research status and molecular mechanism of the traditional Chinese medicine and antitumor therapy combined strategy based on tumor microenvironment, Front. Immunol. 11 (2020) Article ID 609705 (13 pages); https://doi.org/10.3389/fimmu.2020.609705
Search in Google Scholar Back to article
F. Xu, W. Q. Cui, Y. Wei, J. Cui, J. Qiu, L. L. Hu, W. Y. Gong, J. C. Dong and B. J. Liu, Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling, J. Exp. Clin. Cancer Res. 37 (2018) Article ID 207 (16 pages); https://doi.org/10.1186/s13046-018-0878-0
Search in Google Scholar Back to article
T. Chen, P. Yang and Y. Jia, Molecular mechanisms of astragaloside-IV in cancer therapy, Int. J. Mol. Med. 47 (2021) Article ID 13 (13 pages); https://doi.org/10.3892/ijmm.2021.4846
Search in Google Scholar Back to article
Z. Jiang and Z. Mao, Astragaloside IV (AS-IV) alleviates the malignant biological behavior of hepatocellular carcinoma via Wnt/β-catenin signaling pathway, RSC Adv. 9(61) (2019) 35473–35482; https://doi.org/10.1039/c9ra05933d
Search in Google Scholar Back to article
D. Xia, W. Li, C. Tang and J. Jiang, Astragaloside IV, as a potential anticancer agent, Front. Pharmacol. 14 (2023) Article ID 1065505 (15 pages); https://doi.org/10.3389/fphar.2023.1065505
Search in Google Scholar Back to article
T. Cai, C. Zhang, Z. Zhao, S. Li, H. Cai, X. Chen, D. Cai, W. Liu, Y. Yan, K. Xie, H. Pan and X. Zeng, The gastric mucosal protective effects of astragaloside IV in mnng-induced GPL rats, Biomed. Pharma cother. 104 (2018) 291–299; https://doi.org/10.1016/j.biopha.2018.04.013
Search in Google Scholar Back to article
F. Li, K. Cao, M. Wang, Y. Liu and Y. Zhang, Astragaloside IV exhibits anti-tumor function in gastric cancer via targeting circRNA dihydrolipoamide S-succinyltransferase (circDLST)/miR-489-3p/euka ryotic translation initiation factor 4A1(EIF4A1) pathway, Bioengineered 13(4) (2022) 10111–10122; https://doi.org/10.1080/21655979.2022.2063664
Search in Google Scholar Back to article
Z. F. Wang, D. G. Ma, Z. Zhu, Y. P. Mu, Y. Y. Yang, L. Feng, H. Yang, J. Q. Liang, Y. Y. Liu, L. Liu and H. W. Lu, Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts, World J. Gastroenterol. 23(48) (2017) 8512–8525; https://doi.org/10.3748/wjg.v23.i48.8512
Search in Google Scholar Back to article
J. Lin, H. Zhu, L. Hong, W. Tang, J. Wang, H. Hu, X. Wu, Y. Chen, G. Liu, Q. Yang, J. Li, Y. Wang, Z. Lin, Y. Xiao, W. Dai, M. Huang, G. Li, A. Li, J. Wang, L. Xiang and S. Liu, Coexpression of HOXA6 and PBX2 promotes metastasis in gastric cancer, Aging (Albany NY) 13(5) (2021) 6606–6624; https://doi.org/10.18632/aging.202426
Search in Google Scholar Back to article
G. Biffi and D. A. Tuveson, Diversity and biology of cancer-associated fibroblasts, Physiol. Rev. 101(1) (2021) 147–176; https://doi.org/10.1152/physrev.00048.2019
Search in Google Scholar Back to article
X. Chen and E. Song, Turning foes to friends: targeting cancer-associated fibroblasts, Nat. Rev. Drug Discov. 18 (2019) 99–115; https://doi.org/10.1038/s41573-018-0004-1
Search in Google Scholar Back to article
Y. Miyai, N. Esaki, M. Takahashi and A. Enomoto, Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives, Cancer Sci. 111(4) (2020) 1047–1057; https://doi.org/10.1111/cas.14346
Search in Google Scholar Back to article
B. C. Özdemir, T. Pentcheva-Hoang, J. L. Carstens, X. Zheng, C. C. Wu, T. R. Simpson, H. Laklai, H. Sugimoto, C. Kahlert, S. V. Novitskiy, A. De Jesus-Acosta, P. Sharma, P. Heidari, U. Mahmood, L. Chin, H. L. Moses, V. M. Weaver, A. Maitra, J. P. Allison, V. S. LeBleu and R. Kalluri, Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival, Cancer Cell. 25(6) (2014) 719–734; https://doi.org/10.1016/j.ccr.2014.04.005
Search in Google Scholar Back to article
H. Kobayashi, A. Enomoto, S. L. Woods, A. D. Burt, M. Takahashi and D. L. Worthley, Cancer-associated fibroblasts in gastrointestinal cancer, Nat. Rev. Gastroenterol. Hepatol. 16 (2019) 282–295; https://doi.org/10.1038/s41575-019-0115-0
Search in Google Scholar Back to article
Y. Lu, Z. Jin, J. Hou, X. Wu, Z. Yu, L. Yao, T. Pan, X. Chang, B. Yu, J. Li, C. Li, M. Yan, C. Yan, Z. Zhu, B. Liu and L. Su, Calponin 1 increases cancer-associated fibroblasts-mediated matrix stiffness to promote chemoresistance in gastric cancer, Matrix Biol. 115 (2023) 1–15; https://doi.org/10.1016/j.matbio.2022.11.005
Search in Google Scholar Back to article
C. Zhang, L. Li, S. Hou, Z. Shi, W. Xu, Q. Wang, Y. He, Y. Gong, Z. Fang and Y. Yang, Astragaloside IV inhibits hepatocellular carcinoma by continually suppressing the development of fibrosis and regulating pSmad3C/3L and Nrf2/HO-1 pathways, J. Ethnopharmacol. 279(28) (2021) Article ID 114350 (13 pages); https://doi.org/10.1016/j.jep.2021.114350
Search in Google Scholar Back to article
S. Wang, J. Mou, L. Cui, X. Wang and Z. Zhang, Astragaloside IV inhibits cell proliferation of colorectal cancer cell lines through down-regulation of B7-H3, Biomed. Pharmacother. 102 (2018) 1037–1044; https://doi.org/10.1016/j.biopha.2018.03.127
Search in Google Scholar Back to article
K. Jiang, Q. Lu, Q. Li, Y. Ji, W. Chen and X. Xue, Astragaloside IV inhibits breast cancer cell invasion by suppressing Vav3 mediated Rac1/MAPK signaling, Int. Immunopharmacol. 42 (2017) 195–202; https://doi.org/10.1016/j.intimp.2016.10.001
Search in Google Scholar Back to article
J. Zhu and K. Wen, Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells, Phytother. Res. 32(7) (2018) 1289–1296; https://doi.org/10.1002/ptr.6057
Search in Google Scholar Back to article
J. Xiulin, C. Wang, J. Guo, C. Wang, C. Pan and Z. Nie, Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma, Aging (Albany NY) 14(6) (2022) 2819–2854; https://doi.org/10.18632/aging.203977
Search in Google Scholar Back to article
F. Wu, S. Wu, H. Tong, W. He and X. Gou, HOXA6 inhibits cell proliferation and induces apoptosis by suppressing the PI3K/Akt signaling pathway in clear cell renal cell carcinoma, Int. J. Oncol. 54(6) (2019) 2095–2105; https://doi.org/10.3892/ijo.2019.4789
Search in Google Scholar Back to article
S. Wu, F. Wu and Z. Jiang, Effect of HOXA6 on the proliferation, apoptosis, migration and invasion of colorectal cancer cells, Int. J. Oncol. 52(6) (2018) 2093–2100; https://doi.org/10.3892/ijo.2018.4352
Search in Google Scholar Back to article
D. Han, G. Liu, Y. Oh, S. Oh, S. Yang, L. Mandjikian, N. Rani, M. C. Almeida, K. S. Kosik and J. Jang, ZBTB12 is a molecular barrier to dedifferentiation in human pluripotent stem cells, Nat. Commun. 14 (2023) Article ID 632 (16 pages); https://doi.org/10.1038/s41467-023-36178-9
Search in Google Scholar Back to article
Q. Pan, Y. Ning, L. Z. Chen, S. Zhang, Z. Z. Liu, X. X. Yang, W. Wei, H. Wei, Q. G. Li, H. N. Yue and J. X. Wang, Association of MHC class-III gene polymorphisms with ER-positive breast cancer in Chinese Han population, Genet. Mol. Res. 11(4) (2012) 4299–4306; https://doi.org/10.4238/2012.September.17.1
Search in Google Scholar Back to article
S. Bhatlekar, J. Z. Fields and B. M. Boman, HOX genes and their role in the development of human cancers, J. Mol. Med. 92 (2014) 811–823; https://doi.org/10.1007/s00109-014-1181-y
Search in Google Scholar Back to article

Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts through regulation of the HOXA6/ZBTB12 axis

Abstract

Paradigm

My account